Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth
Michael D. Nyquist, … , Elahe A. Mostaghel, Peter S. Nelson
Michael D. Nyquist, … , Elahe A. Mostaghel, Peter S. Nelson
Published June 15, 2021
Citation Information: J Clin Invest. 2021;131(12):e151719. https://doi.org/10.1172/JCI151719.
View: Text | PDF | Amended Article
Corrigendum

Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth

Abstract

Authors

Michael D. Nyquist, Lisa S. Ang, Alexandra Corella, Ilsa M. Coleman, Michael P. Meers, Anthony J. Christiani, Cordell Pierce, Derek H. Janssens, Hannah E. Meade, Arnab Bose, Lauren Brady, Timothy Howard, Navonil De Sarkar, Sander B. Frank, Ruth F. Dumpit, James T. Dalton, Eva Corey, Stephen R. Plymate, Michael C. Haffner, Elahe A. Mostaghel, Peter S. Nelson

×

Full Text PDF | Download (92.14 KB)